4572
vs
LONN
4572
LONN
Over the past 12 months, Carna Biosciences Inc has significantly outperformed LONN, delivering a return of +15% compared to the LONN's 7% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
4572
LONN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Carna Biosciences Inc
TSE:4572
|
329
JPY
|
|||||
|
Lonza Group AG
SIX:LONN
|
536.2
CHF
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
4572, LONN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Carna Biosciences Inc
Revenue
|
|||||||||||
|
|
Lonza Group AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
4572, LONN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Carna Biosciences Inc
TSE:4572
|
|||||||||
|
|
Lonza Group AG
SIX:LONN
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc | ||||
|
|
Lonza Group AG | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
4572, LONN
Performance Gap
4572, LONN
Performance By Year
4572, LONN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
